Pharm 101: Lignocaine

Class

Local anaesthetic
Class IB antiarrhythmic


Pharmacodynamics
  • Class IB antiarrhythmic drug that shortens action potential duration
  • Blocks activated and inactivated Na channels with rapid kinetics
  • Inactivated state block means greater effect on cells with long action potentials such as Purkinje fibres and ventricular cells, compared with atrial cells
  • No effect on conduction

Pharmacokinetics
  • Can be administered via ETT
  • Given IV due to extensive first pass metabolism
  • Half-life 1-2 hours

Clinical uses
  • Arrhythmias associated with MI
  • VT
  • Local anaesthetic
  • Maximum dose:
    • 4mg/kg plain
    • 7mg/kg with adrenaline

Adverse effects
  • Dose-related and short-lived
  • Transient neurological symptoms:
    • Paraesthesias
    • Tremor
    • Nausea
    • Tinnitus
  • Toxicity:
    • CVS: proarrhythmic effects, hypotension in CCF, cardiovascular collapse
    • CNS: metallic taste in mouth, tongue numbness, sedation, hallucinations, seizures

Precautions/contraindications
  • Reduce dose in heart failure or liver disease

Further Reading

Pharm 101 700

Pharmacology 101

Top 200 drugs

MBBS (UWA) CCPU (RCE, Biliary, DVT, E-FAST, AAA) Emergency Medicine Advanced Trainee in Melbourne, Australia. Special interests in diagnostic and procedural ultrasound, medical education, and ECG interpretation. Editor-in-chief of the LITFL ECG Library. Twitter: @rob_buttner

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.